<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2006</study_start_year><condition>Neoplasm Metastasis</condition><condition>Colorectal cancer</condition><condition>Colorectal Neoplasms</condition><condition>Liver Neoplasms</condition><condition>Neoplasms</condition><disease>Neoplasm Metastasis</disease><disease>Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><disease>Liver Neoplasms</disease><disease>Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2122780</full_dataset_link><location>China</location><study_start_month>9</study_start_month><keyword>Chemotherapy</keyword><keyword>Cetuximab</keyword><keyword>Liver metastasis</keyword><repository>ECRIN MDR</repository><study_status>Not provided</study_status></additional><is_claimable>false</is_claimable><name>Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer</name><description>In this study, the investigators assessed the effect of Cetuximab in combination with chemotherapy in the treatment of unresectable metastatic colorectal cancer.</description><dates><creation>2006-09-15</creation></dates><accession>2122780</accession><cross_references><ClinicalTrials___gov>NCT01564810</ClinicalTrials___gov></cross_references></HashMap>